Progressive Care Inc (fka RXMD)

[Jimmy Quick]

ALL IS GOOD
$RXMD $18 Million Acquisition News Previously Released
REAL COMPANY - OTCQB – Penny Stock Exempt, 2 YEARS AUDITED FINANCIALS soon to be 3, Over 20 MILLION NET ANNUAL REVS for 2018 and now over 40 MILLION NET REVENUES with acquisition– HUGE LONGTERM INVESTMENT POTENTIAL. Doubled in Revenues, scripts, and assets with 1 deal.

What's happening for RXMD?

11 things specifically come to mind, and they keep generating more "Game Changers" by the week. WOW!!

1. $18 Million Annual Revenue Purchase of Florida Base Pharmacy (SEE PRESS RELEASE dated 3/12/19 BELOW

Progressive Care Inc. Executes Agreement to Purchase Florida Pharmacies

MIAMI March 12, 2019 Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, announced today the execution of a purchase agreement to acquire a Florida pharmacy with two locations.

On March 8, 2019, Progressive Care Inc. executed an agreement to purchase 100% of the stock in Family Physicians RX, Inc. aka Five Star RX, a Florida corporation (FPRX). FPRX has 2 locations in Florida: Davie and Orlando. FPRX has approximately $18 million in annual revenues and $500,000 in net income as of December 2018, the integration of which would yield $40 million in annual operating revenues for the Company.

The Company has completed phase one of acquiring FPRX through executing a definitive purchase agreement and funding escrow. It anticipates the closing and consolidation into Progressive Care's financial statements to be in the second quarter of 2019. Per state Medicaid rules, the Company has begun the 60 day advance notification regulatory process with the Agency for Health Care Administration (AHCA). Upon receipt of acceptance from AHCA, the Company will effectuate the closing. During this period the Company will prepare and submit paperwork for the change of ownership to the DEA, Insurance Carriers, PBM's, and other associated entities.

"This is the Company's biggest milestone to date," said S. Parikh Mars, CEO of Progressive Care. "In a few months' time, the Company will double in size, move corporate offices into the new building, and begin an exciting new chapter in our story. This acquisition will fundamentally change our reach, status, and longevity in this industry and we look forward to expanding on our momentum and progress."

2. February 2019 revenues were reported. Done – Press Release March 21, 2019

Progressive Care Inc. Announces Strongest February in Company History

MIAMI, FL -- March 21, 2019 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for February 2019.

In February, the company reported a total of $1.7 million in net revenue, a 17% increase from the same month last year, and a 36% increase in prescriptions filled during the same month last year, totaling nearly 26,719 prescriptions filled. Despite industry headwinds through reimbursement compression, network restriction, and formulary reduction, the Company continues its upward growth trend for revenues and prescriptions filled. The Company credits this growth to superior performance reviews and promotion of value-added healthcare service offerings.

"February was another big month for us. Progressive Care exceeded February, 2018 prescription fillings and is moving forward on major initiatives," said S. Parikh Mars, CEO of Progressive Care. "We are currently wrapping up the annual report and working through the acquisition process with licensing and contracting agencies. We are on track to double our revenues post acquisition of FPRX and are confident that 2019 will lead to continued growth, more record-breaking months, and even bigger milestones as we continue our mission to revolutionize the pharmacy industry."

REVENUES ACHIEVED YTD


3. Annual Shareholder Letter for 2019 Forecast and Goals – Done: Press Release 1/17/2019
Ms. Shital Mars, CEO shared the outlook for 2019 and highlights from 2018.

Progressive Care OUTLOOK
The following are our strategic goals for 2019:
• Achieve 40,000 prescriptions filled in a single month
• Increase annual same store sales to $24 million
• Close on second acquisition leading to consolidated revenue of over $35 million
• Secure additional 340B contracts and long-term care facility relationships
• Achieve accreditation for non-sterile compounding
• Achieve full enterprise profitability and earnings growth
• Install Tele-PharmCo enabled kiosks and equipment in senior living communities and large-scale clinics
• Develop exclusive line of CBD products
• Conduct PharmCo evidence-based case studies
• Release PharmCo's first televised advertisement
• Become SEC registered and fully reporting

4. January 2019 revenues will be reported. Done – Feb 20, 2019 PR

Progressive Care Inc. Announces Best January in Company History
Note: I added a few historical details.
Press Release | 02/20/2019

MIAMI, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for January 2019.

In January, the company reported a total of $1.9 million in net revenue, a 5.5% increase from the same month last year, and a 31% increase in prescriptions filled during the same month last year, totaling nearly 31,000 prescriptions filled . This marks the strongest January in Company history. (23,000 for 2018 vs 31,000 for 2019). Revenues matched 2nd Highest total, only trailing 1,930,000 reported in August 2018.

“We started 2019 on a great note. Progressive Care exceeded December 2018 prescriptions filled (28,332) and is moving forward on major initiatives,” said S. Parikh Mars, CEO of Progressive Care. We are confident that our growth strategy will yield results in 2019, allowing us to take the next big steps in our development.”

5. CBD Manufacturer Partnership Agreement

CBD news will be OUT SHORTLY! THEIR SUPPLIERS ARE UPDATING THEIR LABELS AS REQUESTED BY FDA RIGHT NOW!
Putting all the below together and you get….

Armen said they are currently working on the final agreements and some other related work. He is positive this project is moving forward as planned.

Update January 28, 2019
Ms. Mars is flying out to San Diego today. Part of her missions is to meet some CBD organizations for partnership! Armen said he wished the federal government could be more liberal on cannabis products, but no matter what, Progressive Care will be getting the best out of it. He is very much looking forward to this huge opportunity for the company’s growth. As to the potential Curaleaf partnership, he only said they are referring their customers to Curaleaf products as an agreement with Curaleaf. He wants to see where this relationship will lead them to.

So we're going to put our name behind these products, which is a big deal. Again not all CBD is made alike. This is going to be our reputation on the line with the CBD brand and we have two manufacturers that we're working on NDA's with to explore those partnerships. So very exciting times.

6. 3rd Year of Audited Financial Statements and Conference Call to Discuss Results. Completed
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147874305



7. Announcement of SEC Registration Completion

Progressive Care will audit the new Orlando pharmacy’s financials once the acquisition is completed. They will file SEC together. Prior to end of 2019, most likely much much sooner.

8. PharmcoRx Commerical

PharmCoRx Commercial in English and many other languages

https://youtu.be/z642uN9Ppho

9. CBS Miami Interview on “Opioid Weening”

Interviewing CEO Shital Mars, and compounding pharmacist Momina and PharmCo’s patient.

https://www.msn.com/en-us/news/us/custom-made-lotions-provide-patients-with-alternative-to-opioids/vp-BBTSnqn



10. Tele-Pharmacy Licensing Deals

We're are going to be a technology company too. If you look five years from now, CVS, Walgreens, Walmart will be using the solutions we developed and we pioneered and they're going to have to look at us for what we just like the Xerox years ago, had developed all of this tech that were then used by other people.

I don't want to be the Xerox, we're going to own that tech. We're going to be the one you have to come to if you want to advance in the technology sphere of patient management, of healthcare management, of telemedicine, of tele-pharmacy, of whatever. If you're helping a patient and healthcare happens at home, somewhere PharmCo and Progressive Care is going to be involved. So that's the future. That's what we're working toward and that's what all of our shareholders have to look forward to.

11. Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc. Press Release 02/27/2019

MIAMI, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that its wholly owned subsidiary PharmCo, LLC has met all three of the performance measures and is in the top 10% in the nation evaluated by Humana Inc., a leading health and well-being company, as part of its Rx Quality Network program. As a result of PharmCo’s performance scores for 2018, the company will receive the maximum payout offered by Humana as part of the program’s rewards.

ALL OF THIS COULD LEAD TO A SIMILAR SITUATION AS BELOW IN THE FUTURE IN TERMS OF VALUATION – AGAIN HUGE LONGTERM INVESTEMENT POTENTIAL

LOOK AT AMAZONS BUY OF PILLPACK for around $1 Billion, and PillPack revenues were $100 million. RXMD has a ton of revenues. Over $20 million net revenues for FY 2018 and has acquired 2nd location.